Drug
Bevacizumab Hrs 1167
Bevacizumab Hrs 1167: highest development phase Phase 1/2, developed by Jiangsu Hengrui Medicine. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| Bevacizumab； HRS-1167 NCT06308406 | Phase 1/2 | Recurrent Ovarian Cancer |
Latest
No recent events.
Follow Bevacizumab Hrs 1167 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.